Health2Sync
Mobile healthcare solutions
Digital therapeutics
Cloud-based healthcare services
Health insurance products for diabetes patients
Health Management App
Continuous Glucose Monitoring (CGM) Data Integration
Insulin Management Solution
Digital Care Ecosystem
Health Management Services
Health Data Integration Platform
Company name
Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder

49 entries
DateDescription
2013 Acquired ISO 27001:2013 information security management system certification.
2013-06 Health2Sync established in Taiwan.
2014-01 First prototype launched in the US-based TechCrunch Hardware Battlefield.
2014-09 Health2Sync App/Smart Cable/Health2Sync Patient Management Platform officially launched.
2015 Acquired ISO 27017:2015 for cloud computing information security certification.
2015-03 'Partners' function revamped - enabling chat-like instant messaging.
2016-07 Completed A Round of financing.
2016-09 Participated in the Smart Integrated Diabetes Shared Care Program organized by Taiwan's Ministry of Health and Welfare.
2016-11 Health2Sync App reached 100K registered users.
2017-03 Selected as one of the Top 10 Diabetes Apps globally by Healthline.
2017-12 Health2Sync App reached 200K registered users.
2017-12 Completed B Round of financing.
2018-02 Established Japan subsidiary.
2018-04 Selected as one of the Top 10 Diabetes Apps globally by Healthline for the 2nd time.
2018-12 Health2Sync App reached 300K registered users.
2019-03 Selected as one of the Top 10 Diabetes Apps globally by Healthline for the 3rd time.
2019-07 Launched health insurance products for diabetes patients with Taiwan insurers.
2019-09 Partnered with Fitbit to integrate Fitbit data into Health2Sync.
2019-09 Partnered with Novo Nordisk Japan to promote digital health management.
2019-10 Expanded market presence in Malaysia.
2021-02 Partnered with Biocorp to deliver Mallya Technology.
2021-08 Health2Sync App supported CGM data from Abbott's FreeStyle LibreLink App in Japan- First of its kind in Asia.
2021-12 Extended partnership with Sanofi to develop digital insulin management solution.
2021-12 Health2Sync was awarded the 18th National Innoaward in Taiwan.
2022-03 Health2Sync App enabled syncing data from Novo Nordisk’s NovoPen 6 and NovoPen Echo Plus – the company’s latest digital insulin pens.
2022-07 Collaborated with Astra Zeneca to start a digital support program for early CKD detection in Taiwan.
2022-12 Health2Sync App enabled syncing CGM data from Abbott’s FreeStyle LibreLink App in Taiwan, Hong Kong, and Singapore.
2023-01 Reached one million registered users worldwide.
2023-03 Launched integration with Mallya® Cap in Japan together with BIOCORP and Novo Nordisk.
2023-05 Released Health2Sync in the Middle East with Arabic support and worked with Sanofi for market expansion in Egypt.
2023-07 Launched food recognition with AI to make it easier to log meal records.
2023-08 Was selected as one of the top 13 pioneering startups by Taiwan’s National Development Council.
2023-10 Obtained regulatory approval for Insultrate, the first basal insulin titration Software-as-Medical Device approved in Taiwan.
2023-12 Integrated with Sanofi’s SoloSmart in Japan to help improve insulin management.
2023-12 Launched Health2Sync in South Korea with a Korean version of the app.
2024-03 Enabled logging health data through voice recording.
2024-07 Began collaboration with Western Sydney Diabetes to streamline patient care workflow by using our solution.
2024-08 Launched 'DigiCoach,' a CGM-based program co-developed with Singapore's Health Promotion Board to prevent diabetes.
2024-08 Expanded strategic partnerships with Sanofi to promote SoloSmart and SugarGenie in South Korea
2024-08 Nominated as one of Taiwan's top 100 startups by the Taiwan Venture Capital Association (TVCA)
2024-10 Selected by Taiwan's National Health Insurance Administration to participate in the 'Digital Care Reimbursement Project'
2024-11 Integrated Google Health Connect to support syncing vitals and exercise data with other apps.
2025-03 Completed an oversubscribed round of US$20 million.
2025-03 Launched “Lab Report Scanning” function for more efficient lab results tracking.
2025-07 Launched integration with Mallya® Cap in South Korea together with BIOCORP and Novo Nordisk.
2025-08 Listed as Forbes 'Asia 100 To Watch 2025.' Only three Taiwanese companies made the list.
2025-11 Officially listed on the Taiwan Emerging Stock Market (TPEx) under the stock symbol 7851.
2025-12 Introduced 'Advanced AI Food Recognition' to drastically improve accuracy and enable precise volume estimation.
2025-12 Renewed nationwide corporate health insurance ('Kenpo') partnerships with Hitachi and NTT in Japan.
+ Loaded when opened
2026-09-21 18:15 (Model: ggml-org/gpt-oss-20b )
↑